Oncolytic virus–mediated p53 overexpression promotes immunogenic cell death and efficacy of PD-1 blockade in pancreatic cancer

ARAKI, Hiroyuki

doi:10.1016/j.omto.2022.09.003

ID	65331
Title Alternative	膵臓癌における腫瘍融解ウイルス誘導性のp53発現増強は免疫原性細胞死や抗PD-1抗体の治療効果を促進する
FullText URL	K0006770_abstract_review.pdf 359 KB K0006770_fulltext.pdf 612 KB K0006770_other_Graphical_Abstract.pdf 655 KB K0006770_other_fig.pdf 1.39 MB K0006770_other_suppl.pdf 5.57 MB K0006770_summary.pdf 292 KB
Author	ARAKI, Hiroyuki Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Note	岡山大学審査学位論文 This is an Accepted Manuscript of the article: Araki H, Tazawa H, Kanaya N, Kajiwara Y, Yamada M, Hashimoto M, Kikuchi S, Kuroda S, Yoshida R, Umeda Y, Urata Y, Kagawa S, Fujiwara T. Oncolytic virus-mediated p53 overexpression promotes immunogenic cell death and efficacy of PD-1 blockade in pancreatic cancer. Mol Ther Oncolytics. 2022 Sep 13;27:3-13. doi: 10.1016/j.omto.2022.09.003. © 2022 The Author(s). This manuscript version is made available under the CC-BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc-nd/4.0/
Published Date	2023-03-24
Content Type	Thesis or Dissertation
Grant Number	甲第6770号
Granted Date	2023-03-24
Thesis Type	Doctor of Philosophy in Medical Science
Grantor	岡山大学
Thesis FullText	Thesis or Dissertation (See FullText URL)
Related Url	isVersionOf https://doi.org/10.1016/j.omto.2022.09.003
language	English
File Version	ETD
Grant ID	15301甲第6770号
PubMed ID	36212775
Copyright Holders	© 2022 The Author(s).
DOI	10.1016/j.omto.2022.09.003
License	https://creativecommons.org/licenses/by-nc-nd/4.0/